AstraZeneca To Settle Toprol-XL Antitrust Action
AstraZeneca Pharmaceuticals LP reached an agreement Wednesday to resolve claims brought in Delaware by a putative class of indirect purchasers of Toprol-XL who allege the pharmaceutical giant used sham patent litigation...To view the full article, register now.
Already a subscriber? Click here to view full article